A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Clinical trial NCT05091619 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05091619
- Sponsor
- China National Biotec Group Company Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2024-01-22
- Enrollment
- 2898
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.